Thanks to Phil Kerpen on Twitter for regularly doing these, I think they are useful in showing the effect, or lack thereof, of different policy regimes in different states. Minnesota, and Wisconsin, have done pretty well by this metric.
✅ Subscribe via Email
About this Blog
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
February 4, 2023
Coronamonomania Lives Forever, Part 190
Still doing my best to keep you up on the research relevant to the epidemic,…
Commentary
February 3, 2023
Minnesota Dems Go Full-on Crazy
Minnesota has gone full on lunatic in policy.
Commentary
February 3, 2023
(Biggest Sigh Yet) Can We Finally Acknowledge Masks Are Pointless
The most prestigious source for evidence-based medicine and a large study once more demonstrate the…
Interesting. I was disappointed to see that Florida, whom you recently lauded for its approach and outcomes with Covid, fared worse than MN, HI, MA and a couple of others.
Is there a way to download the file
The print is too small to read
thanks
https://www.theburningplatform.com/2021/11/02/uh-thats-not-a-conspiracy-theory/
I had questioned before the concept of a QC problem with the vaccine manufacturing vs. the personal immune system responses to this technology (mRNA) as the driver for the seemingly random medial issues associated with the vaccines. This article seems to suggest that it’s in the manufacturing platform. It drills down into the death counts by lot numbers and finds correlations.
Since it’s (presumably) from the VAERS database directly, it’s hard to put this in the “Tinfoil Hat” category. With the rush to approve, manufacture and distribute, I don’t know why we wouldn’t expect this outcome. I believe these are temperature dependent products which could potentially also explain a supply chain SNAFU on certain lots which might have caused them to be more deadly than others.
It would have been great to see the temporal relationships to better understand if the bad batch/results were dropping over time, meaning that the manufacturing and distribution processes were improving as the roll out took place. Maybe I missed this?